CRISPR screen reveal that FXYD5 is a potential ligand for Siglec-7 9337
Ru Wen(Stratford University), James D. Brooks(Cancer Research Institute), Nathan Lam(Stratford University), Aram Lyu(Fred Hutch Cancer Center), Lawrence Fong(University of California, San Francisco), Eric E. Peterson(Stratford University), Donna M. Peehl(City College of San Francisco), Zhengyuan Qiu(Stratford University), Sharon J. Pitteri, Gerald E. Marti, Hongjuan Zhao(Stanford University)
Cited by 0
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
How many human proteoforms are there?
|Nature Chemical Biology|2018|942